DocGo Inc. Common Stock Q2 2025 Earnings Recap

DCGO Q2 2025 August 8, 2025

Get alerts when DCGO reports next quarter

DocGo delivered strong performance in Q2 2025, highlighted by a substantial cash flow increase and strategic cost reductions, positioning the company for growth amid increasing demand for proactive healthcare solutions.

Earnings Per Share Miss

$-0.11 vs $-0.10 est.

-10.0% surprise

Revenue Beat

80417622 vs 68931400 est.

+16.7% surprise

Market Reaction

1-Day -5.78%

5-Day -8.09%

30-Day -8.67%

See DCGO alongside your other holdings

Add to your portfolio — free

Key Takeaways

Cash flow from operations exceeded $30 million, contributing to a total cash balance of $128.7 million at quarter-end.
Implementation of substantial SG&A reductions is projected to generate $10 million in annualized savings.
Operational metrics met targets with over 176,000 medical transports and significant progress in care gap closure programs.
Customer engagement has surged, with over 1.2 million assigned lives served, and a 50% increase in patient conversions compared to the prior quarter.
Ongoing expansion efforts with significant contracts in new markets position DocGo for robust growth through 2026.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit DCGO on AllInvestView.

Next Q3 2025